Literature DB >> 7200736

Prostaglandin E1 as a hypotensive drug during general anaesthesia.

F Goto, E Otani, S Kato, T Fujita.   

Abstract

Hypotension induced by prostaglandin E1 (PGE1) infusion (100-150 ng/kg/minute) during halothane anaesthesia to reduce operative blood loss during mastectomy was investigated. PGE1 decreased systolic arterial pressure approximately 34% from pre-administration values. The duration of induced hypotension was about 75 minutes. When the infusion was stopped, blood pressure returned to within 15% of the control with 15 minutes. Heart rate did not change significantly during PGE1 infusion; the pre-ejection period and left ventricular ejection period were shortened. Renal function during the hypotensive period was well maintained. Blood loss during surgery was significantly decreased. These findings suggest that PGE1 can be used safely to control arterial pressure during surgery.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7200736     DOI: 10.1111/j.1365-2044.1982.tb01222.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  23 in total

1.  Deliberate hypotension induced by epidural anesthesia.

Authors:  H Katoh; M Furuta; K Ono; U Kondo; T Yamamoto; M Wakamatsu
Journal:  J Anesth       Date:  1993-10       Impact factor: 2.078

2.  Anesthesia for acute pulmonary embolism.

Authors:  S Nakano; C Tashiro; K Sakai; H Shintani; H Takano
Journal:  J Anesth       Date:  1990-10       Impact factor: 2.078

Review 3.  Induced hypotension during anesthesia with special reference to orthognathic surgery.

Authors:  C Rodrigo
Journal:  Anesth Prog       Date:  1995

4.  Lumbar epidural anaesthesia prevented prostaglandin E1-induced diuretic effect in enflurane anaesthetized patients.

Authors:  H Yamaguchi; I Harukuni; S Dohi; S Watanabe; H Naito
Journal:  Can J Anaesth       Date:  1993-07       Impact factor: 5.063

5.  The effect of prostaglandin E1 during cardiopulmonary bypass on renal function after cardiac surgery.

Authors:  K Abe; Y Fujino; T Sakakibara
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  Intra-operative blood pressure control by prostaglandin E1 in patients with hypertension and ischemic heart disease--a multi-center study.

Authors:  S Hoka; J Yoshitake; K Dan; Y Goto; N Honda; T Morioka; T Muteki; Y Okuda; A Shigematsu; M Takasaki; T Totoki; N Yoshimura
Journal:  J Anesth       Date:  1993-04       Impact factor: 2.078

7.  Prostaglandin E1 reduces blood loss during and after resection of lumbar herniated disc.

Authors:  S Kashimoto; T Nakamura; T Yamaguchi
Journal:  J Anesth       Date:  1992-07       Impact factor: 2.078

8.  Effects of prostaglandin E1 on left ventricular performance in dogs; comparisons with trinitroglycerin and adenosine triphosphate.

Authors:  S Hoka; M Sato; H Okamoto; H Arimura; J Yoshitake
Journal:  J Anesth       Date:  1992-01       Impact factor: 2.078

9.  Circulatory and metabolic changes in the brain during induced hypotension--comparison among trimetaphan, glycerin trinitrate and prostaglandin E1.

Authors:  A Kitamura
Journal:  J Anesth       Date:  1991-07       Impact factor: 2.078

10.  Changes in venous capacitance during prostaglandin E1-induced hypotension; comparisons with trinitroglycerin.

Authors:  J Liang; S Hoka; H Okamoto; T Kawasaki; J Yoshitake
Journal:  J Anesth       Date:  1993-07       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.